Recently, the FDA, in direct violation of appropriations language
issued by Congress, finalized a guidance that prohibits traditional pharmacies
from engaging in office use compounding
Office use is when
a physician, in his or her office or other treatment area, administers a
compounded medicinal preparation directly to a patient for the immediate
treatment of a problem. In these instances, a doctor would need to have a
reserve supply of the compounded drugs on hand. This enables doctors to provide
immediate relief to patients who come into their office, or to have a ready
supply for patients whom they have a long history of treating. It also reduces
the cost of the treatment since the medication can be ordered in bulk.
The FDA has ignored our representatives. It is increasingly clear that this agency is not accountable to voters or elected representatives. Write to your member of Congress and tell them that the FDA has ignored their directives, and something must be done.
FDA has ignored Congress on office use guidance
Dear [Decision Maker],
Sincerely,[Your Name] [Your Address] [City, State ZIP][Your Email]